Exane Derivatives’s First Horizon FHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$459 Hold
21
﹤0.01% 579
2022
Q1
$493 Hold
21
﹤0.01% 860
2021
Q4
$343 Hold
21
﹤0.01% 806
2021
Q3
$342 Sell
21
-3,366
-99% -$53.6K ﹤0.01% 975
2021
Q2
$55.8K Buy
3,387
+3,360
+12,444% +$61K 0.01% 641
2021
Q1
$457 Hold
27
﹤0.01% 805
2020
Q4
$345 Hold
27
﹤0.01% 768
2020
Q3
$255 Hold
27
﹤0.01% 715
2020
Q2
$269 Hold
27
﹤0.01% 646
2020
Q1
$218 Hold
27
﹤0.01% 656
2019
Q4
$437 Hold
27
﹤0.01% 624
2019
Q3
$437 Hold
27
﹤0.01% 595
2019
Q2
$403 Hold
27
﹤0.01% 606
2019
Q1
$377 Sell
27
-494
-95% -$7.3K ﹤0.01% 553
2018
Q4
$6.85K Sell
521
-4,793
-90% -$74.6K ﹤0.01% 484
2018
Q3
$91.8K Hold
5,314
0.02% 328
2018
Q2
$96.8K Hold
5,314
0.02% 337
2018
Q1
$98.9K Buy
5,314
+278
+6% +$5.48K 0.02% 303
2017
Q4
$101K Buy
+5,036
New +$96.9K 0.02% 297

Other funds holding FHN

Exane Derivatives's FHN Position: Q2 2022 in Review

Exane Derivatives held its First Horizon (FHN) position steady in Q2 2022 at 21 shares worth $459. The position accounts for ﹤0.01% of the portfolio, ranked #579.

Exane Derivatives first reported a position in FHN in Q4 2017 and has held it in 19 quarters since. The position peaked at $101K in Q4 2017. 554 funds tracked by Wall St. Rank hold FHN as of Q2 2022.

  • Exane Derivatives held 21 shares of First Horizon worth $459 as of Q2 2022.
  • Exane Derivatives left its First Horizon share count unchanged in Q2 2022.
  • First Horizon made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #579 holding.
  • Exane Derivatives first reported a position in First Horizon in Q4 2017 and has held it in 19 quarters since.
  • Exane Derivatives's First Horizon position peaked at $101K in Q4 2017.
  • 554 funds tracked by Wall St. Rank held First Horizon as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.